Macquarie Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Macquarie Group’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,758	Closed	-$128K	–	2371
2018 Q2	$128K	Sell	14,758 -52,937	-78%	-$476K	﹤0.01%	1782
2018 Q1	$687K	Buy	67,695 +33,110	+96%	+$278K	﹤0.01%	1286
2017 Q4	$168K	Buy	34,585 +6,166	+22%	+$30K	﹤0.01%	1781
2017 Q3	$129K	Buy	+28,419	New	+$133K	﹤0.01%	1860

Macquarie Group's JNP Position: Q3 2018 in Review

Macquarie Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 14,758 shares — an estimated $128K sold.

Macquarie Group first reported a position in JNP in Q3 2017 and held it in 4 quarters. The position peaked at $687K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Macquarie Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Macquarie Group sold 14,758 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $128K.
Macquarie Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
Macquarie Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $687K in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Macquarie Group's 13F filing for Q3 2018, filed 15 Nov 2018.